Brain Waves features the clinical, teaching and research endeavors of Le Bonheur Children's Neuroscience Institute.
Le Bonheur is one of the few pediatric hospitals in the country with this level of brain mapping technology and the clinical expertise to improve outcomes for complex epilepsy patients.
Finding Answers: New epilepsy gene screening protocol to help Le Bonheur neurologists target treatments
Children such as Stanislas Ibled are able to find treatment for their frequent seizures using an epilepsy gene panel testing for more than 500 genes associated with seizures in young children.
Epilepsy Center re-accredited as Level 4 center
Le Bonheur's Comprehensive Epilepsy Program at Le Bonheur Children's Hospital has been accredited by The National Association of Epilepsy Centers as a Level 4 Epilepsy Center for 2018-2019.
New leadership for neuropsychology, neuroscience research
Christen Holder, PhD, was recently named clinical director of Neuropsychology in Le Bonheur's Neuroscience Institute. Tracee Ridley-Pryor, DNP, PMHNP-BC-CRC, is now clinical director of Neuroscience Research at Le Bonheur.
Neuroscience Institute earns eighth-straight U.S. News honor
Le Bonheur's Neuroscience Institute has earned its eighth-consecutive "Best Children's Hospital" honor by U.S. News & World Report for top Neurology and Neurosurgery.
FedExFamilyHouse expands to triple in size
Le Bonheur's FedExFamilyHouse - a home away from home for out-of-town families - is undergoing a four-story addition to add 21 new suites and 20 new hotel-style rooms for short visits.
Save the Date: Pediatric Neurology Symposium
The 13th annual Pediatric Neurology Symposium will be April 26-28, 2019. Registration will be available in early 2019. Please watch www.methodistmd.org/cme or call 901-516-8933 for the program.
Case study: Low-grade brainstem glioma
Seventeen-year-old Courtney Coit was referred to Le Bonheur after an MRI revealed a tumor nestled in her brainstem. Pediatric Neurosurgeon Boop and his colleagues have developed a precise surgical approach to treating low-grade brainstem gliomas - a type of tumor notoriously difficult to remove.